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We propose a novel method for refining force-field parameters of protein systems. In this method, the
agreement of the secondary-structure stability and instability between the protein conformations obtained by
experiments and those obtained by molecular dynamics simulations is used as a criterion for the optimization
of force-field parameters. As an example of the applications of the present method, we refined the force-
field parameter set of the AMBER ff99SB force field by searching the torsion-energy parameter spaces of ψ
(N-Cα-C-N) and ζ (Cβ-Cα-C-N) of the backbone dihedral angles. We then performed folding simulations of
α-helical and β-hairpin peptides, using the optimized force field. The results showed that the new force-field
parameters gave structures more consistent with the experimental implications than the original AMBER
ff99SB force field.
I. INTRODUCTION
In the field of molecular simulations of protein systems,
force fields are widely used. The force field is represented
by a sum of potential-energy terms, which are given by
functions and their parameters based on classical me-
chanics. There are several well-known force fields, such as
AMBER1–5, CHARMM6,7, OPLS8,9, GROMOS10, and
ECEPP11. When many researchers perform molecular
simulations of protein systems, these force fields are uti-
lized extensively. Generally, the force-field parameters
are determined based on experimental results for small
molecules and theoretical results using quantum chem-
istry calculations of small peptides such as alanine dipep-
tide.
In a force field, the potential energy is usually com-
posed of the bond-stretching term, bond-bending term,
torsion-energy term, and nonbonded energy term. In
these energy terms, it is known that the torsion-
energy term is the most problematic. For instance,
the ff941 and ff962 versions of AMBER differ only in
the backbone-torsion-energy parameters. Nevertheless,
these secondary-structure-forming tendencies are quite
different12–16. Therefore, many researchers have studied
this energy term and its force-field parameters. Recently,
new force-field parameters of the backbone torsion-
energy term about φ and ψ angles have been devel-
oped, which are, e.g., AMBER ff99SB4, AMBER ff035,
CHARMM 22/CMAP7 and OPLS-AA/L9. Newly pro-
posed methods of the force-field refinement also mainly
concentrate on the torsion-energy terms. These mod-
ifications of the torsion energy are usually based on
quantum chemistry calculations17–21. We have also pro-
posed a force-field refinement method in the previous
works14–16,22–25. These methods are based on the Protein
Data Bank (PDB) and minimize some score functions in
the force-field parameter space. One of the methods con-
sists of minimizing the sum of the square of the force
acting on each atom in the proteins with the structures
from the PDB14–16,24,25. Other approaches use the root-
mean-square deviation between the original PDB struc-
tures and the corresponding minimized structures as the
score functions22,23.
In this article, we introduce a novel optimization
method for force-field parameters, which searches the
lowest value of a score function defined by the sum of
numbers of amino acids, which have secondary-structure
conformations. As an example, we applied this approach
to AMBER ff99SB force field and determined new force-
field parameters for ψ (N-Cα-C-N) and ζ (Cβ-Cα-C-N)
angles. Here, we are using the Greek letter ζ for the
dihedral angle defined by Cβ-Cα-C-N.
In Methods section the details of the methodology are
given. In Results and Discussion section the results of
applications of the optimization method to the AMBER
ff99SB force field are presented. The last section is de-
voted to conclusions.
II. METHODS
A. Force-field parameters
The existing force fields for protein systems such as
AMBER1–5, CHARMM6,7, and OPLS8,9 use essentially
the same functional forms for the potential energy Econf
except for minor differences. The conformational poten-
2tial energy Econf can be written as,
Econf = EBL + EBA + Etorsion + Enonbond , (1)
where, EBL, EBA, Etorsion, and Enonbond represent
the bond-stretching term, the bond-bending term, the
torsion-energy term, and the nonbonded energy term, re-
spectively. Each force field has similar but slightly differ-
ent parameter values. For example, the torsion energy is
usually given by
Etorsion =
∑
dihedral angle Φ
∑
n
Vn
2
[1 + cos(nΦ− γn)] , (2)
where the first summation is taken over all dihedral an-
gles Φ (both in the backbone and in the side chains), n
is the number of waves, γn is the phase, and Vn is the
Fourier coefficient. Namely, the energy term Etorsion has
n, γn, and Vn as force-field parameters.
B. Optimization method of force-field parameters
We now describe our new method for optimizing the
force-field parameters. In this method, we prepare M
protein structures, which are some experimentally deter-
mined conformations. For these proteins, we perform
MD simulations, which start from the experimental con-
formations, by using a trial force field. We try to perform
MD simulations with varied values of force-field parame-
ters. After that, we estimate the “S” value defined by the
following function from the trajectories of theM proteins
obtained from the trial MD simulations:
S =
M∑
i=1
(
nS→Ui
NSi
+
nU→Si
NUi
)
. (3)
Here, nS→Ui is the number of the amino acids in protein i
where their structures in PDB (initial conformation) had
some secondary structures (such as α-helix, 310-helix, pi-
helix, and β structures) but transformed into unstruc-
tured, coil structures without any secondary structures
after a short MD simulation. Likewise, nU→Si is is the
number of amino acids in protein i where their structures
in PDB had coil structures but transformed to have some
secondary structures after a MD simulation. NSi is the
total number of amino acids in protein i which have some
secondary structures in PDB, and NUi is the total num-
ber of amino acids in protein i which have coil structures
in PDB.
When we calculate the S values for the conformations
obtained from MD simulations by using trial force-field
parameters, the parameter set, which yields the mini-
mum S value, is considered to give the optimized force
field. We remark that we want the number of proteinsM
and the total number of time steps of each MD simulation
to be as large as possible in order to reduce the effects
of experimental and systematic errors. In practice, the
available computer power decides them.
III. RESULTS AND DISCUSSION
A. Applications of the optimization method
We present the results of the applications of our op-
timization method presented in the previous section to
the AMBER ff99SB force field. We first chose 31 PDB
files (M = 31) with resolution 2.0 A˚ or better, with se-
quence similarity of amino acid 30.0 % or lower, and with
from 40 to 111 residues (the average number of residues
is 86.7) from PDB-REPRDB26. Namely, the PDB IDs of
these 31 proteins are 1LDD, 1HBK, 1Y02, 1I2T, 1U84,
2ERL, 1TQG, 1O82, 1V54, 1XAK, 1GMU, 1O5U, 1NLQ,
1WHO, 1CQY, 1H75, 1GMX, 1IIB, 1VC1, 1AY7, 1KAF,
1KPF, 1BM8, 1MK0, 1EW4, 1OSD, 1VCC, 1OPD,
1CYO, 1CTF, and 1N9L (these structures are shown
in Fig. 1). We added hydrogen atoms to the PDB
coordinates by using the AMBER11 program package.
We then performed short potential energy minimizations
while restraining the coordinates of the heavy atoms. We
used the obtained conformations as the initial structures.
These initial conformations were used as reference exper-
imental structures in the definition of S in Eq. (3). For
short MD simulations, the unit time step was set to 2.0
fs and the bonds involving hydrogen were constrained by
the SHAKE algorithm27. Each simulation was carried
out for 40.0 ps (hence, it consisted of 20,000 MD steps)
by using Langevin dynamics at 300 K. The nonbonded
cutoff of 20 A˚ were used. As for solvent effects, we used
the GB/SA model28 included in the AMBER program
package (igb = 5). For all the calculations, we used the
AMBER11 program package29.
As the target force-field parameters, we used the pa-
rameters V1 of ψ (N-C
α-C-N) and ζ (Cβ-Cα-C-N) angles
for the torsion-energy term in Eq. (2). We performed the
simulations by using 14 and 15 different values of the V1
parameters of ψ and ζ, respectively, and each simulation
with a fixed set of parameter values was repeated five
times by changing the initial velocities of atoms in the
31 proteins. Namely, we calculated nS→Ui and n
U→S
i in
Eq. (3) as the average numbers of nS→Ui and n
U→S
i of
10 conformations from the last 20.0 ps (within 40.0 ps)
for each simulation (the total number of conformations
was thus 50 for each protein). The results are shown in
Fig. 2. We determined the optimized force-field parame-
ters in order of ζ and ψ, by searching the minimum value
of S in Fig. 2. The optimized V1 value for ζ is −1.60
(while the original value is 0.20), and the optimized V1
value for ψ is 0.31 (while the original value is 0.45).
B. Test simulations of two peptides
In order to test the validity of the force-field parame-
ters obtained by our optimization method, we performed
the folding simulations using two peptides, namely, C-
peptide of ribonuclease A and the C-terminal fragment of
the B1 domain of streptococcal protein G, which is some-
3times referred to as G-peptide30. The C-peptide has 13
residues and its amino-acid sequence is Lys-Glu−-Thr-
Ala-Ala-Ala-Lys+-Phe-Glu-Arg+-Gln-His+-Met. This
peptide has been extensively studied by experiments and
is known to form an α-helix structure31,32. Because
the charges at peptide termini are known to affect he-
lix stability31,32, the N and C termini of the peptide was
blocked with acetyl and N-methyl groups, respectively.
The G-peptide has 16 residues and its amino-acid se-
quence is Gly-Glu−-Trp-Thr-Tyr-Asp−-Asp−-Ala-Thr-
Lys+-Thr-Phe-Thr-Val-Thr-Glu−. The termini were
kept as the usual zwitter ionic states, following the ex-
perimental conditions30,33,34. This peptide is known to
form a β-hairpin structure by experiments30,33,34.
For test simulations, we used replica-exchange molec-
ular dynamics (REMD)35. The unit time step was set to
2.0 fs, and the bonds involving hydrogen were constrained
by the SHAKE algorithm27. Each simulation was carried
out for 30.0 ns (hence, it consisted of 15,000,000 MD
steps) with 32 replicas by using Langevin dynamics. The
replica exchange was tried every 3,000 steps. The tem-
perature was distributed exponentially: 600, 585, 571,
557, 544, 530, 517, 505, 492, 480, 469, 457, 446, 435,
425, 414, 404, 394, 385, 375, 366, 357, 348, 340, 332, 324,
316, 308, 300, 293, 286, and 279 K. As for solvent effects,
we used the GB/SA model28 included in the AMBER
program package (igb = 5). These simulations were per-
formed with different sets of randomly generated initial
velocities.
In Fig. 3, α helicity and strandness of two peptides
obtained from the REMD simulations are shown. For
the original AMBER ff99SB force field, the α helicity is
clearly larger than the strandness in not only C-peptide
but also G-peptide. Namely, the original AMBER ff99SB
force field clearly favors α-helix structure and does not
favor β structure. On the other hand, for the optimized
force field, in the case of C-peptide, the α helicity is larger
than the strandness, and in the case of G-peptide, the
strandness is larger than the α helicity. We can see that
these results obtained from the optimized force field are
in better agreement with the experimental results than
the original force field.
In Fig. 4, 310 helicity and pi helicity of two peptides
obtained from the test simulations are shown. For 310
helicity, the optimized force field does not favor it, while
the original force field favors it to some extent. pi helicity
has almost no value in the both cases of the original and
optimized force fields for the two peptides. As the both
peptides have no 310-helix and pi-helix in the experimen-
tal results, these results of the optimized force field also
have better secondary-structure-forming tendencies than
those of the original force field.
In Fig. 5, the 32 lowest-energy conformations of C-
peptide obtained from the REMD simulations for each
replica in the case of the original and optimized force
fields are shown. In the case of the original force field,
27 conformations have helix structures; 15 of them are
α-helix and 12 are 310-helix. In the case of the optimized
force field, on the other hand, 14 conformations have he-
lix structures, and all of them are α-helix. Moreover,
five conformations are β structures. Both force fields fa-
vor helix structures more than β structures. The original
force field also has some tendency to favor 310-helix struc-
tures, while the optimized force field does not. This result
is consistent with the results of 310 helicity in Fig. 4.
In Fig. 6, the 32 lowest-energy conformations of G-
peptide obtained from the REMD simulations for each
replica are shown. As in the case of C-peptide, 27 confor-
mations obtained from the simulations with the original
force field have helix structures; 11 of them are α-helix,
15 are 310-helix, and one is pi-helix. In the case of the op-
timized force field, 11 conformations have helix structure
(nine are α-helix and two are 310-helix), and 16 confor-
mations have β structures. We see that the optimized
force field slightly favors β structure in agreement with
the experimental implications.
IV. CONCLUSIONS
In this work, we proposed a new optimization method
of force-field parameters and, as an example, optimized
some torsion-energy parameters of the ff99SB force field.
This method can optimize force-field parameters using
PDB structures. We applied these optimization method
using 31 protein molecules from the Protein Data Bank.
We then performed folding simulations of α-helical and
β-hairpin peptides. We found that the 310 helicity of the
optimized force field decreases for both peptides and that
the strandness of the optimized force field increases for
β-hairpin peptide in comparison with those of the orig-
inal ff99SB. The results therefore showed that the opti-
mized force-field parameters gave structures more con-
sistent with the experimental implications than the orig-
inal ff99SB force field. Moreover, the results also showed
that the secondary-structure-forming tendencies depend
strongly on only two parameters of backbone-torsion-
energy term. We are now testing the validity of our
method by the folding simulations of larger proteins.
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